LIA
ARNA

LS Investment Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

LS Investment Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-970
Closed -$42K – 1858
2015
Q1 		$42K Hold
970
– – ﹤0.01% 708
2014
Q4 		$34K Hold
970
– – ﹤0.01% 725
2014
Q3 		$41K Hold
970
– – ﹤0.01% 709
2014
Q2 		$57K Hold
970
– – ﹤0.01% 692
2014
Q1 		$61K Hold
970
– – 0.01% 685
2013
Q4 		$57K Hold
970
– – 0.01% 691
2013
Q3 		$51K Buy
+970
New +$65.1K 0.01% 565

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LS Investment Advisors's ARNA Position: Q2 2015 in Review

LS Investment Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2015, closing a stake of 970 shares — an estimated $42K sold.

LS Investment Advisors first reported a position in ARNA in Q3 2013 and held it in 7 quarters. The position peaked at $61K in Q1 2014. 130 funds tracked by Wall St. Rank hold ARNA as of Q2 2015.

  • LS Investment Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • LS Investment Advisors sold 970 Arena Pharmaceuticals Inc shares in Q2 2015, an estimated $42K.
  • LS Investment Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 7 quarters.
  • LS Investment Advisors's Arena Pharmaceuticals Inc position peaked at $61K in Q1 2014.
  • 130 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2015.

Based on LS Investment Advisors's 13F filing for Q2 2015, filed 31 Jul 2015.